ストックスクリーナーアプリを入手
20.92
0.19%
0.04
前日終値:
$20.88
開ける：
$20.95
24時間の取引高:
895.59K
Relative Volume:
0.98
時価総額：
$1.32B
収益：
$330.50M
当期純損益:
$145.42M
株価収益率:
12.68
EPS:
1.65
ネットキャッシュフロー:
$157.96M
1週間 パフォーマンス:
+14.07%
1か月 パフォーマンス:
+4.81%
6か月 パフォーマンス:
+15.71%
1年 パフォーマンス:
+13.63%
1日の値動き範囲:
$20.76
$21.13
1週間の範囲:
$18.89
$21.13
52週間の値動き範囲:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
INVA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.92 | 1.32B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-11 | 開始されました | Oppenheimer | Outperform |
| 2025-07-14 | 開始されました | H.C. Wainwright | Buy |
| 2025-07-11 | 開始されました | Cantor Fitzgerald | Overweight |
| 2025-03-07 | 開始されました | Scotiabank | Sector Outperform |
| 2024-06-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2022-07-20 | 開始されました | Goldman | Neutral |
| 2017-11-20 | 開始されました | Deutsche Bank | Hold |
すべてを表示
Innoviva Inc (INVA) 最新ニュース
What earnings revisions data tells us about Innoviva Inc.July 2025 PostEarnings & Weekly Hot Stock Watchlists - Newser
Does Innoviva Inc. fit your quant trading modelShort Setup & Advanced Technical Analysis Signals - Newser
Will Innoviva Inc. continue its uptrendPortfolio Gains Summary & Target Return Focused Stock Picks - Newser
Innoviva (NASDAQ:INVA) Upgraded to Strong-Buy at Wall Street Zen - Defense World
Can trapped investors hope for a rebound in Innoviva Inc.Earnings Performance Report & Accurate Buy Signal Notifications - Newser
Is Innoviva Inc. reversing from oversold territoryProduct Launch & Free Reliable Trade Execution Plans - Newser
Visual analytics tools that track Innoviva Inc. performance2025 Historical Comparison & Weekly Setup with High ROI Potential - Newser
Pattern recognition hints at Innoviva Inc. upsideQuarterly Market Summary & Reliable Price Action Trade Plans - Newser
How Innoviva Inc. stock performs during market volatilityPortfolio Performance Report & Reliable Entry Point Trade Alerts - Newser
What risks could impact Innoviva Inc. stock performanceWeekly Market Report & AI Enhanced Trade Execution Alerts - Newser
Is Innoviva Inc. trading at a discountTrade Risk Summary & Long-Term Capital Growth Strategies - thegnnews.com
Is it time to cut losses on Innoviva Inc.Gold Moves & Real-Time Chart Breakout Alerts - Newser
What data driven models say about Innoviva Inc.’s futureJuly 2025 Reactions & Growth Focused Stock Reports - Newser
Earnings visualization tools for Innoviva Inc.July 2025 Rallies & Community Supported Trade Ideas - Newser
HC Wainwright Predicts Increased Earnings for Innoviva - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by US Bancorp DE - Defense World
Sentiment analysis tools applied to Innoviva Inc.Quarterly Trade Report & Technical Entry and Exit Tips - Newser
Tools to monitor Innoviva Inc. recovery probabilityJuly 2025 PreEarnings & Precise Swing Trade Entry Alerts - Newser
Equities Analysts Set Expectations for Innoviva Q3 Earnings - Defense World
Key External Factors That Drive Innoviva Inc. Stock Price MovementsTake Profit & Precise Swing Trade Entry Alerts - Newser
Armata Pharmaceuticals Announces Second Quarter 2025 Results and Provides Corporate Update - The Malaysian Reserve
Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA® and XACDURO® Nominated for the 2025 Prix Galien USA Best Pharmaceutical Product Award - itemonline.com
Innoviva Specialty Therapeutics’ Antimicrobial Therapies ZEVTERA - Business Wire
Is Innoviva Inc. a defensive stockWeekly Stock Report & Capital Efficient Trade Techniques - newsyoung.net
Innoviva (NASDAQ:INVA) versus Eli Lilly and Company (NYSE:LLY) Head to Head Survey - Defense World
Innoviva (NASDAQ:INVA) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World
Is Innoviva Inc. being accumulated by smart moneyWealth Building Stock Watchlist - classian.co.kr
Sentiment Turns Positive on Innoviva Inc. — Reversal AheadRisk Adjusted Technical Entry Plan Gains Followers - sundaytimes.kr
Is Innoviva Inc. a play on infrastructure spendingFree Watchlist with Entry Points - newsyoung.net
Innoviva’s Royalties Keep Cash Flowing Despite Mixed Market Returns - Finimize
Innoviva (NASDAQ:INVA) Stock Price Up 8.2% Following Analyst Upgrade - Defense World
Why Innoviva (INVA) Is Up 5.7% After Reporting a Return to Profitability in Q2 - simplywall.st
Results: Innoviva, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
Innoviva’s Commercial Bet Pays Off As Shares Jump - Finimize
HC Wainwright Raises Innoviva Price Target to $45.00, Boosts Buy Rating - AInvest
Innoviva's Q2 Earnings Outperform Expectations; Price Target Raised to $45 by H.C. Wainwright - AInvest
Expert Outlook: Innoviva Through The Eyes Of 4 Analysts - 富途牛牛
Innoviva's Specialty Therapeutics, Royalty Portfolio to Drive Outperformance, Oppenheimer Says - MarketScreener
Analysts Initiate Coverage on Arm Holdings with Bullish Predictions - AInvest
This Arm Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Benzinga
Innoviva, Inc. Just Recorded A 54% EPS Beat: Here's What Analysts Are Forecasting Next - simplywall.st
Innoviva, Inc. Just Beat EPS By 54%: Here's What Analysts Think Will Happen Next - ca.finance.yahoo.com
Zurcher Kantonalbank Zurich Cantonalbank Cuts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Inc Q2 2025 Earnings: Revenue Misses Estimates, EPS at $1.01, Royalty Revenue at $67.3 Million - AInvest
Innoviva Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Avantax Advisory Services Inc. Has $372,000 Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva Reports Strong Q2 2025 Financial Results - The Globe and Mail
Innoviva: Q2 Earnings Snapshot - New Haven Register
Innoviva Inc (INVA) 財務データ
収益
当期純利益
現金流量
EPS
Innoviva Inc (INVA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
0.41%
0.88%
大文字化:
|
ボリューム (24 時間):